Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | mTOR inhibitor used in kidney transplant and rare tumours. | Anti-rejection medicine after transplants. |
| Body system | Joints & Immunity | Joints & Immunity |
| Drug class | mTOR inhibitors | Calcineurin inhibitors |
| Supply | Prescription only | Prescription only |
| Main uses | Kidney transplant rejection prevention, Lymphangioleiomyomatosis | Preventing transplant rejection, Eczema (ointment), Lupus nephritis (specialist) |
| How it works | Stops immune cells attacking a transplanted organ. | Stops immune cells attacking a transplanted organ. |
| Starts working | Weeks | — |
| Half-life | About 62 hours | About 12 hours (variable) |
| Typical adult dose | 2 mg once a day after loading, adjusted to blood levels. | Weight-based starting doses, then adjusted to trough blood levels. |
| Forms | Tablet, Oral solution | Capsule, Modified-release capsule, Granules, Injection, Ointment |
| Common side effects | Mouth ulcers, Raised cholesterol, Swollen ankles, Acne, Slow wound healing | Tremor, Headache, High blood pressure, High blood sugar |
| Serious side effects | Serious infections, Lung inflammation, Poor wound healing, Lymphoma and skin cancer | Kidney damage, Infections, Skin cancer and lymphoma, Diabetes |
| Don't take if | Lung transplant (bronchial anastomotic dehiscence); Pregnancy; Liver transplant (early use) | — |
| Alcohol | Best to limit. Alcohol adds to liver strain. | — |
| Pregnancy | Usually avoidedAvoid; effective contraception advised. | Use with cautionContinued after transplant with specialist care. |
| Breastfeeding | Usually avoidedAvoid. | — |
| In use since | — | 1994 |
| Brand names | United States: Rapamune, FyarroUnited Kingdom: RapamuneIndia: Rapamune, Sirolimus (generic), Sirolimus Biocon | United States: Prograf, Envarsus XR, ProtopicUnited Kingdom: Prograf, Advagraf, Adoport, ProtopicIndia: Pangraf, Tacrograf |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | L04AA10 | L04AD02 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker